Tags

Type your tag names separated by a space and hit enter

Molecular genetic advances in neurodegenerative disorders.
Clin Lab Med. 1995 Dec; 15(4):915-26.CL

Abstract

Advances in molecular genetics have had a major impact on our understanding of the pathogenesis of neurologic disorders. This article discusses molecular genetic contributions to our knowledge of Huntington's disease, amyotrophic lateral sclerosis, and Alzheimer's disease, as well as their implications for diagnosis and treatment. Specific, sensitive testing for Huntington's disease is now possible; elucidation of the pathogenesis of familial amyotrophic lateral sclerosis has been achieved and has launched promising drug trials; and the heterogeneity and pathogenetic complexity of Alzheimer's disease have been revealed.

Authors+Show Affiliations

Department of Pathology, Medical College of Virginia, Richmond 23298-0662, USA.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

8838230

Citation

Aguilera, A J.. "Molecular Genetic Advances in Neurodegenerative Disorders." Clinics in Laboratory Medicine, vol. 15, no. 4, 1995, pp. 915-26.
Aguilera AJ. Molecular genetic advances in neurodegenerative disorders. Clin Lab Med. 1995;15(4):915-26.
Aguilera, A. J. (1995). Molecular genetic advances in neurodegenerative disorders. Clinics in Laboratory Medicine, 15(4), 915-26.
Aguilera AJ. Molecular Genetic Advances in Neurodegenerative Disorders. Clin Lab Med. 1995;15(4):915-26. PubMed PMID: 8838230.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Molecular genetic advances in neurodegenerative disorders. A1 - Aguilera,A J, PY - 1995/12/1/pubmed PY - 1995/12/1/medline PY - 1995/12/1/entrez SP - 915 EP - 26 JF - Clinics in laboratory medicine JO - Clin Lab Med VL - 15 IS - 4 N2 - Advances in molecular genetics have had a major impact on our understanding of the pathogenesis of neurologic disorders. This article discusses molecular genetic contributions to our knowledge of Huntington's disease, amyotrophic lateral sclerosis, and Alzheimer's disease, as well as their implications for diagnosis and treatment. Specific, sensitive testing for Huntington's disease is now possible; elucidation of the pathogenesis of familial amyotrophic lateral sclerosis has been achieved and has launched promising drug trials; and the heterogeneity and pathogenetic complexity of Alzheimer's disease have been revealed. SN - 0272-2712 UR - https://www.unboundmedicine.com/medline/citation/8838230/Molecular_genetic_advances_in_neurodegenerative_disorders_ DB - PRIME DP - Unbound Medicine ER -